Literature DB >> 32569589

Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency.

Min-Zhi Peng1, Xiu-Zhen Li1, Hui-Fen Mei1, Hui-Ying Sheng1, Xi Yin1, Min-Yan Jiang1, Yan-Na Cai1, Ling Su1, Yun-Ting Lin1, Yong-Xian Shao1, Li Liu2.   

Abstract

BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is pleomorphic congenital hyperammonemia, in which the prognosis of the patient is determined both by genotype and environmental factors. This study investigated the clinical and biochemical characteristics of OTCD patients with different prognosis.
METHOD: Of 35 OTCD patients, six males deceased at the first disease-onset, 17 males survived and had controllable ammonia levels after treatment, and 12 females survived through the first disease-onset but had intractable hyperammonemia and high mortality. Fasting blood samples from patients collected at three disease stages were used for the analysis of amino acid (AA) profile, acylcarnitine profile, and micronutrients. Differences in profiles between patients and healthy controls and within patient groups were studied.
RESULTS: All OTCD patients had accumulation of glutamine, homocitrulline, lysine, glutamate, cystathionine, and pipecolic acid, as well as deficiency of citrulline, tryptophan, threonine, and carnitine. For male non-survivors, most other AAs and long-chain acylcarnitines were elevated at disease onset, of which the levels of creatine, N-acetylaspartic acid, and homoarginine were remarkably high. Male survivors and female patients had most other AAs at low to normal levels. Compared with male survivors, female patients had much lower protein-intolerance, as indicated by significantly lower levels of protein consumption indicators, including essential AAs, 1-methylhistidine, acylcarnitines et al., but high levels of ammonia. Female patients still had significantly higher levels of citrulline, homocitrulline, and citrulline/arginine compared to male survivors.
CONCLUSION: Unique profiles were observed in each group of OTCD patients, indicating specific physiological changes that happened to them.
Copyright © 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acylcarnitine; Amino acid; Choline; Hyperammonemia; N-acetylaspartic acid; Urea cycle disorder

Mesh:

Substances:

Year:  2020        PMID: 32569589     DOI: 10.1016/j.clinbiochem.2020.06.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

Review 1.  The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.

Authors:  Laura Taina-González; María de la Fuente
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

2.  Prenatal Diagnosis of Two Common Inborn Errors of Metabolism by Genetic and Mass Spectrometric Analysis of Amniotic Fluid.

Authors:  Congcong Shi; Sitao Li; Yu Gao; Zhirong Deng; Hu Hao; Xin Xiao
Journal:  Front Pediatr       Date:  2022-02-09       Impact factor: 3.418

Review 3.  Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Authors:  Mahsa Ghasemzad; Mahdieh Hashemi; Zohre Miri Lavasani; Nikoo Hossein-Khannazer; Haleh Bakhshandeh; Roberto Gramignoli; Hani Keshavarz Alikhani; Mustapha Najimi; Saman Nikeghbalian; Massoud Vosough
Journal:  Bioengineering (Basel)       Date:  2022-08-15

Review 4.  Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects.

Authors:  Sebastián Scioli Montoto; Giuliana Muraca; María Esperanza Ruiz
Journal:  Front Mol Biosci       Date:  2020-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.